Dorsey Wright & Associates Codexis, Inc. Transaction History

Dorsey Wright & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 31, 2019	SELL	$12.75 - $19.01 $14,994 - $22,355	-1,176 Closed	0 $0
Q2 2019 Jul 02, 2019	BUY	$17.0 - $21.88 $4,998 - $6,432	294 Added 33.33%	1,176 $22,000
Q1 2019 Apr 04, 2019	SELL	$15.53 - $22.15 $13,697 - $19,536	-882 Reduced 50.0%	882 $18,000
Q4 2018 Jan 07, 2019	BUY	$14.06 - $22.57 $4,133 - $6,635	294 Added 20.0%	1,764 $29,000
Q3 2018 Oct 12, 2018	BUY	$13.35 - $19.1 $19,624 - $28,077	1,470 New	1,470 $25,000

131

49.5M

33.4K

21K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $210M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.